Tiny movements, big impact? hourly activity program aims to protect rural Women's hearts
NCT ID NCT07704749
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This pilot study tests whether a simple program of brief, frequent movement throughout the day can help reduce cardiometabolic risk in rural women. Participants wear a Fitbit that reminds them to move each hour and complete health assessments before and after the 12-week program. The study focuses on whether the program is feasible to run in routine clinic care and looks for early signs of improvement in risk factors like blood pressure and waist circumference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a 12-week program of brief, frequent light-to-moderate movement each waking hour, supported by a Fitbit Inspire 3 activity tracker with hourly reminders
- What this could lead to
- If successful, this approach could offer a simple, scalable way to prevent heart disease and diabetes in rural women who face barriers to traditional exercise programs.
- What could go wrong
- This is a small, single-group pilot study with no comparison group, so results may not prove the program works. Adherence to hourly movement may be challenging for some participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 125 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Female, aged 18 to 80 years Physically inactive, defined as less than 150 minutes of moderate-intensity physical activity per week (by self-report) Metabolic syndrome, defined as three or more cardiometabolic risk factors consistent with NCEP ATP III criteria, based on documented diagnosis or clinical history: waist circumference \>88 cm; blood pressure ≥130/85 mmHg; fasting blood glucose ≥100 mg/dL; triglycerides ≥150 mg/dL; HDL cholesterol \<50 mg/dL Access to a personal or household smartphone (Apple iOS 16.4 or higher, or Android OS 11.0 or higher) capable of installing the Fitbit application; no cellular data plan required Working email address Able to understand and provide written informed consent in English or Spanish Receiving care at one of the three Larry Combest Community Health \& Wellness Center sites Exclusion Criteria: Current pregnancy or planning to become pregnant during the study period Medical conditions that preclude safe participation in light-to-moderate physical activity (e.g., unstable cardiovascular disease, uncontrolled hypertension, severe musculoskeletal limitations), as determined by the PI through EHR review Participation in another structured lifestyle or cardiometabolic intervention study within the past 6 months (self-report) Use of medications or treatments that significantly alter inflammation or metabolism (e.g., systemic corticosteroids, recent chemotherapy), as determined by the PI through EHR review Inability to comply with study procedures, including wearing the activity tracker or completing follow-up assessments No access to a smartphone, or a smartphone unable to run the Fitbit application due to operating system incompatibility
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiometabolic risk factors are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Texas Tech University Health Sciences Center Clinical Research Institute
Lubbock, Texas, 79430, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Longevity metrics AI/ML development study: a standing data library and Model-Development platform for predicting and validating health measurements, longevity, and disease
- Do obese children with autism face different heart risks?
- Digital twin of the human body may forecast health decline before it happens
- Could cutting Ultra-Processed foods reverse childhood metabolic syndrome?
- Weekly shot after gestational diabetes may shield new mothers from metabolic syndrome
- A blood marker may reveal hidden heart risk in rheumatoid arthritis